Czechia· CZ-0285816
DAGETIA
A dapagliflozin product containing dapagliflozin propylene glycol monohydrate, registered in Czechia by Medochemie Ltd., Limassol. The same ATC class is registered in 16 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Dapagliflozin is registered in 16 of 19 countries.
Countries holding a registration under ATC A10BK01 (dapagliflozin), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 9 of them publish a price we can compare per daily dose
Dapagliflozin · ATC A10BK01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dapagliflozin costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.33 in United States to $4.38 in Switzerland — a ×13 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Dapagliflozin · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.38
- IT Italy$3.42
- US United States$0.33 (acquisition cost)
The record
At a glance
SÚKL (Czech Republic)- Active substance
- DAPAGLIFLOZIN PROPYLENE GLYCOL MONOHYDRATE
- Manufacturer
- Medochemie Ltd., Limassol
- Country
- Czechia (CZ)
- ATC code
- A10BK01
- ATC class
- Dapagliflozin
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
426 interactions on record for dapagliflozin.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dapagliflozin · interactions on record
426 records
- 1 severe
- 378 moderate
- 47 minor
Most severe, free to view
- SucralfateA02BX02moderate
- PapaverineA03AD01moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dapagliflozin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDAPAGLIFLOZINPrasco Laboratories
- FinlandDapagliflozin KrkaKRKA d.d. Novo mesto
- BelgiumDapagliflozin EG 5 mgEG
- IrelandDapagliflozin Clonmel 5 mg film-coated tabletsClonmel Healthcare Ltd
- GermanyDapagliflozin CiplaCipla Europe Nv
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Austria · Dapagliflozin Denk
- Germany · Dapagliflozin Cipla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/24f46d1f-f075-4221-b5b4-e5ab2e8d08d3 GET /v1/drugs/24f46d1f-f075-4221-b5b4-e5ab2e8d08d3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "5MG",
"pack_size": "98 KAL",
"substance": "DAPAGLIFLOZIN PROPYLENE GLYCOL MONOHYDRATE",
"cz_kod_sukl": "0285816",
"product_type": "CH",
"substance_codes": "19747",
"registration_state": "R",
"registration_number": "18/277/23-C"
}See everything about dapagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.